Stock 8158 CHINA REGENERATIVE MEDICINE INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights China Regenerative Medicine International Limited

Equities

8158

KYG2129W1380

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:08 2024-06-27 EDT 		5-day change 1st Jan Change
0.165 HKD 0.00% Intraday chart for China Regenerative Medicine International Limited +0.61% -70.00%
04-02 China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2020
CI
China Regenerative Medicine International Limited Enters into Non-Legally Binding Memorandum of Understanding with Jinxin Holdings Co, Ltd
CI
Link Asia International MedTech : to Form Stem Cell Storage JV with Chinese Firm
MT
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
China Regenerative Medicine International Limited Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Full Year Ended December 31, 2019
CI
China Regenerative Medicine International Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019
CI
BLB International Company Limited cancelled the acquisition of 11.37% stake in China Regenerative Medicine International Limited from All Favour Holdings Limited.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8158 Stock
  4. News China Regenerative Medicine International Limited
  5. Highlights